Friess Associates LLC Eli Lilly & CO Transaction History

Friess Associates LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$110.79 - $129.32 $1.61 Million - $1.88 Million	-14,500 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$111.31 - $131.02 $1.61 Million - $1.9 Million	-14,500 Reduced 50.0%	14,500 $1.88 Million
Q4 2018 Feb 14, 2019	BUY	$105.9 - $118.64 $3.07 Million - $3.44 Million	29,000 New	29,000 $3.36 Million

4,011

751M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Friess Associates LLC, based on Form 13F filings with the SEC.

Stay updated on Friess Associates LLC with notifications on news.